Silo Pharma (SILO) Research & Development (2020 - 2026)

Silo Pharma has disclosed Research & Development across 7 years of filings, most recently posting $298418.0 for Q2 2026.

• In Q2 2026, Research & Development fell 58.39% year-over-year to $298418.0; the TTM figure through Jun 2026 stood at $518699.0 (down 82.14% YoY), while the FY2025 annual figure was $518225.0, down 78.12% from the prior year.
• Research & Development came in at $298418.0 for Q2 2026 at Silo Pharma, down from $1.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $1.1 million in Q4 2024 to a low of -$1.3 million in Q4 2025.
• Average Research & Development over 5 years is $348098.1, with a median of $356380.0 recorded in 2022.
• Year-over-year, Research & Development surged 458.12% in 2022 and plunged 224.25% in 2025.
• Over 5 years, Research & Development stood at $634684.0 in 2022, then slumped by 46.91% to $336965.0 in 2023, then surged by 219.24% to $1.1 million in 2024, then sank by 224.25% to -$1.3 million in 2025, then soared by 122.33% to $298418.0 in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $298418.0 in Q2 2026, $1.0 million in Q1 2026, and -$1.3 million in Q4 2025.